SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas will participate on a panel at BioFlorida's 10th annual conference titled "Raising Capital" on October 17 in Weston, FL.
News | 10. 17. 2007
